- Home
- SAFE vs MNKD Comparison
SAFE vs MNKD Comparison
Compare SAFE & MNKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAFE
- MNKD
- Stock Information
- Founded
- SAFE 2016
- MNKD 1991
- Country
- SAFE United States
- MNKD United States
- Employees
- SAFE N/A
- MNKD N/A
- Industry
- SAFE Real Estate Investment Trusts
- MNKD Biotechnology: Pharmaceutical Preparations
- Sector
- SAFE Real Estate
- MNKD Health Care
- Exchange
- SAFE Nasdaq
- MNKD Nasdaq
- Market Cap
- SAFE 1.1B
- MNKD 1.1B
- IPO Year
- SAFE 2017
- MNKD 2004
- Fundamental
- Price
- SAFE $14.71
- MNKD $4.06
- Analyst Decision
- SAFE Buy
- MNKD Buy
- Analyst Count
- SAFE 9
- MNKD 6
- Target Price
- SAFE $22.33
- MNKD $9.33
- AVG Volume (30 Days)
- SAFE 397.2K
- MNKD 3.0M
- Earning Date
- SAFE 08-05-2025
- MNKD 08-06-2025
- Dividend Yield
- SAFE 4.80%
- MNKD N/A
- EPS Growth
- SAFE N/A
- MNKD 228.27
- EPS
- SAFE 1.46
- MNKD 0.10
- Revenue
- SAFE $391,206,000.00
- MNKD $297,595,000.00
- Revenue This Year
- SAFE $0.32
- MNKD $13.72
- Revenue Next Year
- SAFE $5.07
- MNKD $14.94
- P/E Ratio
- SAFE $10.09
- MNKD $39.14
- Revenue Growth
- SAFE 2.64
- MNKD 32.50
- 52 Week Low
- SAFE $13.68
- MNKD $3.51
- 52 Week High
- SAFE $28.80
- MNKD $7.63
- Technical
- Relative Strength Index (RSI)
- SAFE 41.10
- MNKD 55.84
- Support Level
- SAFE $14.65
- MNKD $3.74
- Resistance Level
- SAFE $15.43
- MNKD $4.13
- Average True Range (ATR)
- SAFE 0.41
- MNKD 0.14
- MACD
- SAFE -0.05
- MNKD 0.05
- Stochastic Oscillator
- SAFE 8.63
- MNKD 88.14
About SAFE Safehold Inc. New
Safehold Inc is a REIT that operates its business by acquiring, managing, and capitalizing ground leases. Ground leases are long-term contracts between the landlord (the Company) and a tenant or leaseholder. Ground leases generally represent ownership of the land underlying commercial real estate projects that are net leased by the fee owner of the land to the owners/operators of the real estate projects built thereon.
About MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of inhaled therapeutic products for patients with diseases such as diabetes and pulmonary arterial hypertension. Its approved product, Afrezza (insulin human) Inhalation Powder, is an ultra-rapid-acting inhaled insulin used to improve glycemic control in adults with diabetes. The product consists of a dry powder formulation of human insulin delivered from a small portable inhaler.